NPI Lens

Robert C. Rawdin, D.D.S.

NPI 1265605828ActiveIndividual· Dentist, Prosthodontics· New York, NY

Dentist, Prosthodontics (D.D.S.) in New York, New York, licensed in NY, with an NPI issued in April 2008. Part D covered 32 prescriptions written in 2024, 91% of them generic. Geistlich Pharma, North America, Inc. reported $196.54 in payments in 2025, mostly food and beverage.

Overview

NPI1265605828
StatusActive
Entity typeIndividual
CredentialD.D.S.
Sole proprietorNo
NPI issuedApr 3, 2008
Last updated in NPPESApr 9, 2018

Specialties and licenses

TaxonomyCodeLicenseState
Dentist, Prosthodontics Primary1223P0700X038253NY

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)32 · 36 30-day fills
Patients19
Total drug cost$652.80
Generic share91% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$196.54 · 1 payment from 1 company
  • 2024$412.19 · 4 payments from 3 companies

Top paying companies in 2025

CompanyAmountPayments
Geistlich Pharma, North America, Inc.$196.541

What the 2025 payments were for

  • Food and Beverage$196.54 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Dentist, Prosthodontics providers in New York

All Dentist, Prosthodontics providers in New York →